QuidelOrtho’s infectious disease test portfolio spans the healthcare continuum from point-of-care settings to high-throughput laboratories and is critical in addressing the growing syphilis epidemic ...
QuidelOrtho Corporation QDEL recently announced the addition of the ARK Fentanyl II Assay to its U.S. Vitros XT 7600 and 5600 Integrated Systems as well as its Vitros 4600 Chemistry System menu of ...
SAN DIEGO, Aug. 13, 2025 /PRNewswire/ -- QuidelOrtho Corporation (QDEL) has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results